Cyclooxygenase 2 controversy: thoughts on the process of discovery, development, and assessment of benefit and risk of therapies for chronic immunoinflammatory diseases of uncertain autoimmune etiology.

Authors :: Furst DE
Khanna D
Paulus HE
Source :: Arthritis and rheumatism [Arthritis Rheum] 2006 Oct 15; Vol. 55 (5), pp. 683-6.
Publication Year :: 2006

Subjects :: Anti-Inflammatory Agents, Non-Steroidal adverse effects
Anti-Inflammatory Agents, Non-Steroidal economics
Anti-Inflammatory Agents, Non-Steroidal therapeutic use
Autoimmunity physiology
Chronic Disease
Cyclooxygenase 2 Inhibitors adverse effects
Cyclooxygenase 2 Inhibitors economics
Drug Approval
Humans
Immune System Diseases immunology
Immune System Diseases physiopathology
Inflammation immunology
Inflammation physiopathology
Risk Assessment
Cyclooxygenase 2 Inhibitors therapeutic use
Immune System Diseases drug therapy
Inflammation drug therapy

Full Text Access

Tools